BORTEZOMIB

Hospira, Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 27, 2023
Approval ID: 9fdf6169-699f-40eb-bda1-760253062b3c
Products: 2 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous useInitial U.S. Approval: 2003

Quick Stats

Total Products2

Labelers2

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.